Whitehawk Therapeutics (WHWK) Profit After Tax (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Profit After Tax data on file, last reported at -$22.3 million in Q1 2026.

• On a quarterly basis, Profit After Tax fell 130.59% year-over-year to -$22.3 million in Q1 2026; TTM through Mar 2026 was -$116.0 million, a 519.61% decrease from a year earlier, with the FY2025 full-year figure at -$20.5 million, up 67.83% from the prior year.
• Profit After Tax for Q1 2026 stood at -$22.3 million, up from -$23.3 million in the prior quarter.
• Over the last five years, Profit After Tax for WHWK reached as high as $73.0 million in Q1 2025 and fell as low as -$52.6 million in Q2 2025.
• Historically, Profit After Tax has averaged -$13.7 million across 5 years, with a median of -$16.4 million in 2023.
• Across the five-year window, Profit After Tax plunged 1089.39% in 2022 and surged 499.15% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$13.9 million in 2022, then fell by 17.65% to -$16.4 million in 2023, then decreased by 11.82% to -$18.3 million in 2024, then fell by 27.14% to -$23.3 million in 2025, then increased by 4.04% to -$22.3 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$22.3 million in Q1 2026, -$23.3 million in Q4 2025, and -$17.7 million in Q3 2025.